We are passionate about the well-being of patients. We are convinced that digital therapies make a valuable, global contribution to better healthcare. We think and act independently.
We develop innovative tools and solutions that enable real progress and improvements in therapy standards for patients in a connected world. We are actively shaping the transformation to digital healthcare solutions.
We combine excellence in healthcare, digitalization, regulations and marketing to create unique interdisciplinary expertise. Our cosmopolitan team of experts has extensive experience in inhalation therapy.
We believe in a world where all people with chronic respiratory diseases have access to optimal therapy support, regardless of income, background or level of education.
Classification of Kata as a Class IIa medical device (CE) (MDR)
First pharma partner to use Kata in clinical trials
Kata® now has 1000 users
1.5 million Euro financing round with existing shareholders and two new investors
First selective contract with a German health insurance company
South East Asia Program of the German Accelerator
Seal of Excellence - Horizon 2020 research and innovation program of the EU
Classification of Kata as a class I medical device (CE) (MDD)
VisionHealth closes another growth financing deal
EU funding - Horizon 2020 program
Kata® available in the App Store (on iOS and Android)
Successful usability study of the Kata App V1.0
First working prototype of the Kata® algorithm
Foundation of the VisionHealth GmbH
Sabine Häußermann and Philipp Kroneberg meet at the DGP and develop the common idea of Kata®
VisionHealth designs and implements innovative digital health solutions of the highest quality that enable real progress and improvements in therapy standards for patients and their caregivers in a connected world.
The dynamic team has made a name for itself in respiratory medicine, IT and regulatory affairs.
The directors are recognized specialists in pneumology as well as respiration and possess many years of outstanding experience in their fields.